BRIEF published on 09/17/2024 at 18:50, 1 year 2 months ago EssilorLuxottica unveils its future headquarters in Paris Innovation Sustainability Paris EssilorLuxottica Head Office
PRESS RELEASE published on 09/17/2024 at 18:45, 1 year 2 months ago EssilorLuxottica unveils plans for its new corporate headquarters in Paris EssilorLuxottica announces plans for new global headquarters in Paris at Place Valhubert, Paris 13e, embracing innovation, sustainability, and employee well-being Innovation Sustainability Paris EssilorLuxottica Global Headquarters
BRIEF published on 09/17/2024 at 07:39, 1 year 2 months ago EssilorLuxottica and Meta Extend Partnership to Shape Future of Smart Eyewear EssilorLuxottica Smart Eyewear Wearables Meta Platforms Ray-Ban
PRESS RELEASE published on 09/17/2024 at 07:34, 1 year 2 months ago EssilorLuxottica and Meta Announce Long Term Partnership, Shaping the Future of the Smart Eyewear Category EssilorLuxottica and Meta extend partnership to develop multi-generational smart eyewear products, revolutionizing wearables. Ray-Ban Meta glasses redefine connected living Partnership Meta EssilorLuxottica Smart Eyewear Ray-Ban Meta Glasses
BRIEF published on 08/29/2024 at 19:51, 1 year 3 months ago EssilorLuxottica: Successful Euro 2 Billion Bond Issuance at 2.99% Euronext Paris Institutional Investors Bond Issuance EssilorLuxottica Euro 2 Billion
PRESS RELEASE published on 08/29/2024 at 19:46, 1 year 3 months ago EssilorLuxottica: successful Euro 2 billion bond issuance at 2.99% EssilorLuxottica successfully issues Euro 2 billion bonds at 2.99%, attracting quality institutional investors. Proceeds for general corporate purposes Institutional Investors Financial Market Corporate Purposes EssilorLuxottica Euro 2 Billion Bonds
BRIEF published on 07/26/2024 at 18:35, 1 year 4 months ago EssilorLuxottica: Publication of the 2024 Interim Financial Report Financial Statements 2024 Interim Report Board Approval EssilorLuxottica
PRESS RELEASE published on 07/26/2024 at 18:30, 1 year 4 months ago EssilorLuxottica: Publication of the 2024 Interim Financial Report EssilorLuxottica publishes 2024 Interim Financial Report, includes Management Report, Financial Statements, and Auditor's Review. Download from website Financial Statements Investors EssilorLuxottica 2024 Interim Financial Report Ophthalmic Lenses
BRIEF published on 06/18/2024 at 18:50, 1 year 5 months ago EssilorLuxottica and Diesel announce 10-year licensing agreement Diesel Fashion License Agreement EssilorLuxottica Glasses
PRESS RELEASE published on 06/18/2024 at 18:45, 1 year 5 months ago EssilorLuxottica and Diesel announce a ten-year licensing agreement EssilorLuxottica and Diesel announce a 10-year licensing agreement for Diesel eyewear. The first collection under the deal will be available in Q1 2025, combining Diesel's style with EssilorLuxottica's craftsmanship Licensing Agreement Collaboration Diesel Eyewear EssilorLuxottica
Published on 12/05/2025 at 02:35, 3 hours 26 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 5 hours 1 minute ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 6 hours 56 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 1 minute ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 2 hours 30 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 10 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 9 hours 35 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 9 hours 46 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 10 hours 50 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 12 hours 1 minute ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 16 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 12 hours 16 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 23 hours ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 12 hours ago Declaration of voting rights at the end of November 2025
